OR WAIT null SECS
George Okafo is a manager in Scinovo, Preclinical Development at GlaxoSmithKline (UK).
April 02, 2010
The authors describe a novel approach for assessing method robustness. This article contains online-bonus material and was copublished with Pharmaceutical Technology Europe.